Drew Costello is a Partner at FRA based in Philadelphia, Pennsylvania. Drew specializes in the areas of Forensic Accounting and Corporate Compliance with over 20 years of experience in both professional services and industry roles.
Drew provides investigative services for attorneys, corporate management, and governmental agencies pertaining to a variety of matters, including bribery and corruption, earnings management, false claims, conflicts of interest, commercial disputes as well as general fraud and misconduct schemes. Mr. Costello has significant experience guiding companies through regulatory investigations involving the DOJ and SEC, including those resulting the appointment of independent compliance monitors.
Drew also assists clients in establishing and strengthening compliance, ethics and anti-fraud programs and internal controls to mitigate the evolving risks of digitalization and regulation. Mr. Costello has direct experience in leading companies through all stages of compliance program maturity, from establishing a foundation of policy development and global awareness training, procedural development of core compliance activities, to embedding a risk-based monitoring and auditing protocol. Drew’s compliance advisory services have also been performed in support of a DPA-imposed independent compliance monitor.
Prior to joining FRA, Drew was a Director of Compliance Audit at Teva Pharmaceuticals where he managed and delivered proactive audits assessing compliance and fraud risk related to FCPA, Anti-Kickback Statute, False Claims Act, antitrust laws, data privacy, and restricted promotional practices in the US and over 80 global affiliates.
Who’s Who Legal has recognized Drew as a Global Leader and Forensic Accounting expert. Sources describe him as “the consummate professional” and have noted his “great strategic thinking with an understanding of the legal issues.”
Drew is a Certified Public Accountant (CPA) licensed in Pennsylvania, a Certified Fraud Examiner (CFE), and is Certified in Financial Forensics (CFF).
Drew’s community involvement includes serving as a board member of Breakthrough Challenge, a non-profit organization, whose primary mission is to support breakthrough research at Penn Medicine's Abramson Cancer Center.